KRAS and neoplasm: These results are consistent with the fact that tumours derived from K-Ras-transformed Perk−/− MEFs (mouse embryonic fibroblasts) display less angiogenesis and grow less rapidly than tumours with an intact UPR signalling [175], demonstrating the role of PERK activation in the angiogenic process.